Initia is proud to announce the successful completion of a pioneering clinical study at Shamir Medical Center (Assaf Harofeh Hospital), evaluating the use of Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT) with a vaginal probe for the treatment of female Stress Urinary Incontinence (SUI). The trial, designed as a single-blind randomized controlled study, was conducted using our innovative MoreNova® device.
Breakthrough Findings Presented at ESSM 2024
The results of this important study were recently presented by Dr. Anna Padoa, Head of Urogynecology and Pelvic Floor Service at Shamir Medical Center, during the ESSM 2024 Conference in Bari, Italy. Her presentation highlighted the promise of MoreNova® therapy as a non-surgical, patient-friendly alternative for women suffering from SUI, a condition that impacts millions worldwide.
Recognition at ICS 2024 in Madrid
In addition to these presentations, an abstract based on the study has been accepted for podium presentation at the International Continence Society (ICS) 2024 Conference in Madrid this October — further underscoring the clinical relevance and international recognition of the research.
A Collaborative Effort
We extend our deepest gratitude to the dedicated team of physicians and researchers who made this study possible:
- Dr. Anna Padoa
- Dr. Eyal Levy
- Dr. Anna Tsviban
- Dr. Roni Tomashev
- Dr. Tal Fligelman
Advancing Women’s Health
This milestone reflects Initia’s ongoing commitment to advancing research and developing non-invasive, regenerative solutions in women’s health. By working alongside leading clinicians and medical institutions, we continue to push the boundaries of what shockwave therapy can achieve in restoring function, improving quality of life, and expanding treatment options.